Explore more publications!

Women’s Health, Maternal Care Witnesses Improvement in China

(MENAFN) Women across China experienced ongoing advancements in overall well-being throughout 2024, accompanied by strengthened maternal healthcare provisions.

This information comes from a statistical monitoring document issued on Tuesday by the National Bureau of Statistics, as reported by a news agency.

The report highlighted that the maternal death rate stood at 14.3 per 100,000 in 2024, reflecting a 5.3 percent decline compared to 2023.

These figures were part of the assessment of the China National Program for Women's Development (2021-2030).

Additionally, the rate of premarital medical examinations climbed to 77.1 percent in 2024, marking a 0.5 percentage point increase from the previous year, according to the same report.

During 2024, authorities in China introduced a review mechanism aimed at directing regional medical and health facilities to refine their treatment frameworks and strengthen their ability to care for expectant and postpartum women facing urgent or critical conditions.

This initiative contributed to the creation of a broad emergency response network that is layered and effectively coordinated. As a result, emergency medical services for pregnant women have been enhanced, ensuring greater protection and safety, the report emphasized.

MENAFN30122025000045017167ID1110539254


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions